ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping
出版年份 2015 全文链接
标题
ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 70, Issue 5, Pages 1367-1380
出版商
Oxford University Press (OUP)
发表日期
2015-01-29
DOI
10.1093/jac/dku545
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ebola emergency meeting establishes new control centre
- (2014) Andrew Green LANCET
- Mission to MERS
- (2014) M. Enserink SCIENCE
- Human Monkeypox
- (2013) A. M. McCollum et al. CLINICAL INFECTIOUS DISEASES
- Emergence of Cowpox: Study of the Virulence of Clinical Strains and Evaluation of Antivirals
- (2013) Sophie Duraffour et al. PLoS One
- An Increasing Danger of Zoonotic Orthopoxvirus Infections
- (2013) Sergei N. Shchelkunov PLoS Pathogens
- The Munich Outbreak of Cutaneous Cowpox Infection: Transmission by Infected Pet Rats
- (2012) A Wollenberg et al. ACTA DERMATO-VENEREOLOGICA
- Pharmacokinetic and Pharmacodynamic Modeling To Determine the Dose of ST-246 To Protect against Smallpox in Humans
- (2012) Janet M. Leeds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers
- (2012) Jarasvech Chinsangaram et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic Comparison of a Single Oral Dose of Polymorph Form I versus Form V Capsules of the Antiorthopoxvirus Compound ST-246 in Human Volunteers
- (2012) Jarasvech Chinsangaram et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®
- (2012) Élida Santos-Fernandes et al. ANTIVIRAL RESEARCH
- Come fly with me: Review of clinically important arboviruses for global travelers
- (2012) Natalie Cleton et al. JOURNAL OF CLINICAL VIROLOGY
- Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5
- (2012) M. M. Lorenzo et al. JOURNAL OF GENERAL VIROLOGY
- Investigation of the First Laboratory-Acquired Human Cowpox Virus Infection in the United States
- (2012) Andrea M. McCollum et al. JOURNAL OF INFECTIOUS DISEASES
- Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001
- (2012) E. R. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Mutations Conferring Resistance to Viral DNA Polymerase Inhibitors in Camelpox Virus Give Different Drug-Susceptibility Profiles in Vaccinia Virus
- (2012) S. Duraffour et al. JOURNAL OF VIROLOGY
- Template-based protein structure modeling using the RaptorX web server
- (2012) Morten Källberg et al. Nature Protocols
- Camelpox virus
- (2011) Sophie Duraffour et al. ANTIVIRAL RESEARCH
- Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge
- (2011) Inge Vliegen et al. ANTIVIRAL RESEARCH
- Generalized cowpox infection in a patient with Darier disease
- (2011) O. Haase et al. BRITISH JOURNAL OF DERMATOLOGY
- Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus
- (2011) S. K. Smith et al. JOURNAL OF VIROLOGY
- Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification
- (2011) Darin S. Carroll et al. PLoS One
- Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: A novel expanding zoonosis
- (2011) H.G. Schatzmayr et al. VACCINE
- Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects
- (2010) R. Jordan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Toward the estimation of the absolute quality of individual protein structure models
- (2010) Pascal Benkert et al. BIOINFORMATICS
- Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice
- (2010) Aklile Berhanu et al. VACCINE
- Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246
- (2010) Debra C. Quenelle et al. Viruses-Basel
- ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease Manifestation
- (2009) A. Berhanu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification
- (2009) R. Jordan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246
- (2009) J. Huggins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The other nanotech
- (2009) Nature Nanotechnology
- Protein structure prediction on the Web: a case study using the Phyre server
- (2009) Lawrence A Kelley et al. Nature Protocols
- Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis
- (2009) Yali Chen et al. Virology Journal
- Zoonotic Infections of Buffalopox in India
- (2009) V. Bhanuprakash et al. Zoonoses and Public Health
- In Vitro Efficacy of ST246 against Smallpox and Monkeypox
- (2008) S. K. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model
- (2008) Aysegul Nalca et al. ANTIVIRAL RESEARCH
- Severe Eczema Vaccinatum in a Household Contact of a Smallpox Vaccinee
- (2008) Surabhi Vora et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More